AzTrials
AzTrials

Pain, PostoperativeNCT06563622

Pericapsular Nerve Group Block Versus Caudal Block for Postoperative Pain Management in Pediatric Hip Surgery

A study testing Pericapsular Nerves Group Block and Caudal Epidural Block in people with Pain, Postoperative, run by Benha University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Children can experience substantial pain after hip operations, causing agitation, depression, and sleep disruption, which can have a negative impact on their health. Opioids are associated with several serious side effects that limits its use as solo agents for pain management. Read more about this study

Who is it for?
Ages 1 year to 7 years
Conditions the study is for
Pain, Postoperative
What is being tested?
Pericapsular Nerves Group Block and Caudal Epidural Block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteEgypt
Study dates
10 Aug 2024to 20 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 7 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • child aged 1- 7 years old
  • American Society of Anesthesiologists (ASA) physical status I-II
  • scheduled for elective hip surgery under general anesthesia

Who cannot join

  • parents/guardians refusal to participate
  • known local anesthetic drug sensitivity,
  • bleeding disorders,
  • pre-existing infection at the block site, and
  • the presence of major cardiac, renal, or hepatic disorders.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Samar Rafik Mohamed Amin

    Banhā, Qalyubia Governorate, 13511

Other trials in Egypt

About this study

Official title: Ultrasound-Guided Pericapsular Nerve Group Block Versus Ultrasound-Guided Caudal Block for Postoperative Pain Management in Pediatric Hip Surgery; a Randomized Controlled Trail

Children can experience substantial pain after hip operations, causing agitation, depression, and sleep disruption, which can have a negative impact on their health. Opioids are associated with several serious side effects that limits its use as solo agents for pain management. Regional blocks such as caudal Block (CB) and pericapsular nerve group (PENG) block in adjuvant with general anaesthesia are alternative perioperative analgesic techniques that lead to lesser side effects, including motor weakness, postoperative nausea and vomiting with decreased opioid consumption.

Read the detailed description

Regional anesthesia is often used to prevent postoperative pain in pediatric surgery. Combined with general anesthesia (GA), ultrasound (US)-guided regional anesthetic approaches provide simple intraoperative pathway that reduced GA requirements, lower pain score with less impact on the respiratory or cardiovascular system

In pediatric surgery, caudal block (CB) is a low-cost, simple, and effective procedure for postoperative analgesia. CB is suggested for most surgeries in the lower body, primarily below the umbilicus. Although the well-established anesthetic properties of CB, its action terminates early in the postoperative period and it has a number of restrictions, such as anatomical abnormalities or infection at the injection site, that can prevent its use

PENG block is the plane lying between the psoas muscle and tendon and the ilio-pubic eminence. The single-shot PENG block has lately been reported in the cadaveric study and in the literature for perioperative pain management in hip surgery by aiming the articular arms of the accessory obturator nerve (AON), femoral nerve (FN), and obturator nerve (ON). The technical simplicity of imaging in traction-fixed patients and no need for multiple punctures made this blockage ideal for young pediatric patients. Unfortunately, there are no adequate studies regarding PENG block in patients younger than five years old.

This study was carried out to assess ultrasound-guided PENG block versus CB for their efficacy, safety and pain management in pediatric hip surgery.

Being tested
Pericapsular Nerves Group Block, Caudal Epidural Block
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pericapsular Nerves Group BlockProcedure or surgery

    Also called PENG Block

    USG-guided single-shot PENG in a dose of 0.5 ml/kg of 0.25% bupivacaine per side.

  • Caudal Epidural BlockProcedure or surgery

    Also called CEB

    USG-guided single-shot CEB in a dose of 0.5 mL/kg of 0.25% bupivacaine.

Study groups in NCT06563622
Study groupRoleWhat they receive
Group PExperimentalIn ultrasound-guided pericapsular nerve group block Group , the patient will be positioned in a supine position. The anatomical landmarks, including ilio-pubic eminence, the iliopsoas muscle and tendon, the femoral artery and vein, and the pectineus muscle, will be identified using a 9-12 MHz superficial linear transducer. A lateral to medial in-plane technique will be used to insert a 22-gauge, 50-mm needle. the needle's tip will be positioned at the musculofascial plane, located between the ilio-pubic ramus posteriorly and the psoas tendon anteriorly. Following negative aspiration to avoid intravascular injection, 0.5-1 ml of normal saline will be injected to confirm the correct needle site. A 0.5 ml/kg plain bupivacaine 0.25% will be injected.
Receives: Procedure: Pericapsular Nerves Group Block
Group CActive comparatorthe caudal epidural block will be established in the lateral decubitus position, the high-frequency linear transducer will be first placed transversely at the midline to obtain a "frog eye" sign view of the sacral cornu, the sacro-coccygeal ligament, the sacrum, and the sacral hiatus. At this position, the USG transducer will be rotated by 90° to obtain a longitudinal view. The needle will be inserted in-plane into the sacral canal and the Local anaesthetics will be injected under real-time visualization by a dose of 0.5 ml/kg plain bupivacaine 0.25%.
Receives: Procedure: Caudal Epidural Block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain score with FLACC

    (Face, Legs, Activity, Cry, and Consolability scale to assess pain in young children. Each category is scored on a 0-2 scale which results in a total score between 0 (lowest pain) and 10 (worst pain).

    Measured: 30 minutes postoperative, 1 hour postoperative, 2 hour postoperative, and 6 hours postoperative

Secondary outcomes (5)
  1. The duration of the block

    from immediately after the block administration until the first postoperative rescue analgesia.

    Measured: immediately after the intervention, up to 24 hours postoperative

  2. the Time to first postoperative rescue analgesia

    it will be administered if the FLACC score is ≥ 4/10.

    Measured: 24 hours postoperative

  3. Total rescue analgesia consumption

    total dose of Morphine administrated as rescue opioid

    Measured: 24 hours postoperative

  4. The incidence of postoperative adverse effects

    including nausea , vomiting , localized hematoma, bradycardia, hypo-tension, and Pruritis.

    Measured: 24 hours postoperative

  5. Parents satisfaction score

    using a 5- point Likert score (0 = very dissatisfied, 1=dissatisfied, 2 = neither satisfied nor dissatisfied, 3 = satisfied and 4 = very satisfied)

    Measured: 24 hours postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2024
  2. Study start10 Aug 2024
  3. Primary completion1 Apr 2025
  4. Study completion20 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06563622
Sponsor's protocol ID
RC.30.9.2023
Status last verified
Nov 2025
First submitted
13 Aug 2024
Last updated
28 Nov 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Pericapsular Nerves Group Block and Caudal Epidural Block in people with Pain, Postoperative, run by Benha University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain score with FLACC (time frame: 30 minutes postoperative, 1 hour postoperative, 2 hour postoperative, and 6 hours postoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in